Furthermore, galanthamine is a competitive and selective AChE inhibitor having brain-selective properties like rivastigmine and donepezil, used in the clinical treatment of AD and is metabolized by the cytochrome P450 enzyme. This evidence concerns the gene ACHE and Alzheimer disease.